BOULDER, Colo.--(BUSINESS WIRE)--
SomaLogic, Inc., a privately held healthcare company focused on the
application of its novel proteomics technology to life science research
and healthcare diagnostics, will present at the 32nd Annual J.P. Morgan
Healthcare Conference in San Francisco on January 13, 2014. Byron
Hewett, Chief Executive Officer, will discuss the company’s goals and
progress in a presentation scheduled to begin at 8:00am PST (11:00am
SomaLogic, Inc., is a privately held protein biomarker discovery, life
science tools and clinical diagnostics company based in Boulder, Colo.
The company's mission is to use its proprietary aptamer-based proteomic
technology to develop a wide range of enhanced protein-analysis tools
and reagents for life sciences, to facilitate protein biomarker
discovery and validation for therapeutic applications, and to develop
and commercialize clinical diagnostic products aimed at improving health
care by offering timely and accurate health information to physicians
and their patients. Further information about SomaLogic can be found at www.somalogic.com.
Fintan R. Steele, Ph.D., +1-720-214-3080
Director of Communications
Source: SomaLogic, Inc.